The criteria that selected these women as high-risk group were a BRCA1/2 pathogenic variant present in the family, patient or a FDR with two or more primary breast cancers, ovarian cancer, breast cancer before age 45 or male breast cancer, or had a combination of three or more specific cancers present in the family. The gene discussed is BRCA1; the disease is ovarian cancer.